The present invention relates to agents based on integrase of HIV-1, for inhibiting the proliferation of HIV-1. The agents are derived from the C-terminal domain of HIV-1 integrase, comprising at least one of the regions identified as being important for interaction between integrase and imp7 or imp.beta., and/or for nuclear localization of the HIV PIC, replication of HIV, or infection of HIV.